Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Breast Cancer Health Center

Font Size

Old Breast Cancer Drug Still No. 1


But while the oncology group is passing on aromatase inhibitors for now, they are not closing the door on the drugs. Winer says that there are ongoing studies that "may present sufficient data within two or three years, so we are going to revisit this issue every year."

Moreover, he says that even with the new recommendations, there are some women who should be getting aromatase inhibitors instead of tamoxifen. "Women with a history of blood clotting disorders would be good candidates for aromatase inhibitors because tamoxifen can increase the risk for clot formation," he says.

In addition, some women who have never had breast cancer before but are at a high risk for breast cancer take tamoxifen as a way to lower their risk. "So it is pretty much a no-brainer that if one of these women develops breast cancer, she is obviously not a good candidate for more tamoxifen, so an aromatase inhibitor would be a better choice."

And not all of the oncologists at the meeting agree with the new guidelines. Paul Goss, MD, director of the Breast Cancer Prevention Program at Princess Margaret Hospital in Toronto and professor of medicine at the University of Toronto, Ontario, said he believes "these recommendations are too cautious." He points out that for more than 15 years there has been ample evidence that limiting estrogen production is an effective way to prevent breast cancer.

For doctors and patients who decide to follow the tamoxifen recommendation, Kathy Albain, MD, professor of medicine at Loyola University Cardinal Bernardin Cancer Center in Chicago, says that there is a right and wrong way to take tamoxifen. She says that results of a study of 1,477 postmenopausal women with breast cancer suggest that taking tamoxifen at the same time as chemotherapy "reduces tamoxifen's benefit by half."

To get the maximum benefit, tamoxifen should be initiated after chemotherapy is completed, usually about six months after surgery.

1 | 2

Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
Breast Cancer Treatments Improving
Resolved To Quit Smoking
Woman getting mammogram
Screening Tests for Women
ovarian cancer overview slideshow
serious woman
what is your cancer risk
10 Ways to Revitalize Slideshow